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SIXTY·THIRD HONOR LECTURE
DELIVERED AT THE UNIVERSITY
A basic objective of the Faculty Association of Utah State University, in the words of its constitution, is:
to encourage intellectual growth and development of its members
by sponsoring and arranging for the publication of two annual
faculty research lectures in the fields of (1 ) the biological and
exact sciences, including engineering, called the Annual Faculty
Honor Lecture in the Natural Sciences; and (2) the humanities
and social sciences, including education and business administration, called the Annual Faculty Honor Lecture in the Humanities.
The administration of the University is sympathetic with these aims
and shares, through the Scholarly Publications Committee, the costs of
publishing and distributing these lectures.
Lecturers are chosen by a standing committee of the Faculty
Association. Among the factors considered by the committee in choosing
lecturers, are in the words of the constitution:
( 1) creative activity in the field of the proposed lecture; (2) publication of research through recognized channels in the field of the
proposed lecture ; (3) outstanding teaching over an extended
period of years; (4 ) personal influence in developing the character
of the students.
Thomas Emery was selected by the committee to deliver the Annual
Faculty Honor Lecture in the Sciences. On behalf of the members of
the Association we are happy to present Professor Emery's paper.

Committee on Faculty Honor Lecture

IRON AND LIFE
by
Thomas Emery*

Iron: The Problem
Iron, iron, everywhere but. . . . The plight of the ancient mariner
surrounded by undrinkable water could hardly have been more frustrating than life on earth with respect to iron. Iron is the fourth most
abundant element of the earth's surface, exceeded only by oxygen, silicon,
and aluminum. Virtually all forms of life from the simplest bacteria to
humans require iron to catalyze numerous and complex metabolic
reactions. Because of the diversity and complexity of the role of iron
in the life process, it has even been suggested that the origin of life
on earth centered around the catalytic properties of this metal. But
in spite of its abundance, the acquisition of iron for cellular needs is a
formidable problem. The fact that one of every four persons in western
civilization suffers from iron-deficiency anemia is testimony to the fact
that the problem has not been resolved.
To understand the nature of the problem itself, we need only to
review what we learned about iron in freshman chemistry. In solution,
iron commonly occurs as either the ferrous form, Fe++, or the ferric form,
Fe+++. The ferrous form is quite soluble even at the neutral conditions of
living cells. In contrast, if one neutralizes an acidic solution of the ferric
ion, the iron precipitates out of solution under conditions which are still
one hundred times more acidic than water itself. In fact, a simple
calculation shows that in the neutral environment of living cells only
one or two atoms of iron could remain in solution within the cell. When
life evolved on earth, there was no oxygen in the atmosphere. Iron thus
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remained in the ferrous state, and in this soluble form it was plentiful
in the oceans and other bodies of water. With the evolution of photosynthesis, oxygen appeared in the atmosphere. Very quickly the ferrous
form of iron was oxidized to the ferric form. Geological evidence shows
that vast deposits of ferric oxides were precipitated from the oceans at
this time. Quickly the amount of dissolved iron decreased to an infinitesimal amount, far too small to support life. The manner in which the
powerful forces of evolution allowed life to adapt to an environment
virtually devoid of a soluble, utilizable form of iron will be the subject
of this paper. Most of the research in this area involves microorganisms.
However, a reader patient enough to follow the discussion to the end
will be rewarded by learning of recent developments which may directly
relate to his or her own health and well-being, facts which at the time of
this writing are not widely appreciated even by practicing physicians.
With the appearance of oxygen on earth, most of the iron soon
became converted to insoluble ferric silicate or ferric oxide. The red
color of many soils and rock formations, particularly striking in the cliffs
and arches in the Southwest of the United States, is due to ferric oxide.
Given a sample of ferric oxide which he wishes to solubilize, a chemist
has two choices. First, he may simply add acid. In acid, the iron quickly
dissolves to give a yellow solution of the ferric ion. The second method
is to add a substance called a chelating agent. A chelating agent is an
organic compound which has a strong affinity for metal ions and which
literally pinches the metal like a pair of pliers. In fact, the word chelate
derives from the Greek word, chele, meaning the claw of a lobster.
In general, chelates are very soluble in water.
Primitive living cells utilized the same method. In order to survive,
they soon "learned" to synthesize relatively simple organic molecules that
were effective chelating agents for iron. These substances were excreted
into the environment where they effectively solubilized the metal. Because
these natural iron chelates are colored bright red, we call them siderochromes, from the Greek sideros, iron, and chroma, color. In addition
to being chelating agents, many siderochromes are at the same time
organic acids. We have recently observed in our laboratory that during
the growth of certain iron-starved microorganisms, the excretion of
siderochromes may be accompanied by an increase in acid concentration
one thousand times above that of the original culture. Thus, nature
utilizes the same tricks as the chemist (or vice versa) to solubilize iron.
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Over a billion years elapsed before the first siderochrome was discovered
in 1952 by Professor J. B. Neilands at the Berkeley campus of the
University of California (Neilands, 1952). I became involved in the
problem several years later.

The Solution: Ferrichrome
In the fall of 1956 I was a graduate student in the Biochemistry
Department at Berkeley in quest of a thesis problem. I had almost
decided to work in the laboratory of Professor Arthur Pardee. He had
told me of a fascinating idea he had about how single cells could control
their metabolic activity, and he patiently explained to me how he might
be able to prove his idea by studying the inhibition of an enzyme called
aspartate transcarbamoylase. It was an exciting idea, but in the end
I decided not to work with Professor Pardee for two reasons. First, I was
trained as an organic chemist, and enzymes frightened me a little.
Second, Professor Pardee frightened me a lot. Instead, I chose Professor
J. B. Neilands as my thesis supervisor. Another student, John Gerhardt,
went to work with Professor Pardee and today is an internationally
renowned biochemist for his important work on the aspartate transcarbamoylase enzyme.
Several years before my arrival as a student at Berkeley, Neilands
had been carrying out research in microbial iron metabolism. He had
chosen to study a fungus, Ustilago sphaerogena, because this organism
had been reported to have an exaggerated iron metabolism. When
grown in a normal, iron-containing medium, U. sphaerogena produces
up to 1 % of its own weight in an iron protein, cytochrome c. Neilands
observed that when the organism was deprived of iron it excreted large
amounts of a new substance which turned deep red when iron was
added to it. Neilands was able to isolate and crystallize small amounts
of this new iron compound. Because it contained ferric ion and it was
brightly colored, he named it ferrichrome. One day as I passed Neilands
in the hallway of the Biochemistry building he thrust a small vial containing about twenty-five milligrams of ferrichrome into my hand and
said to me, "I hear you are looking for a thesis problem. If you want
a good one, figure out the chemical structure of this stuff. " I decided
to accept the challenge, not knowing that another student had spent
nearly two years on the problem and left in discouragement.
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After eighteen months of hard work, I had accumulated five large
notebooks of experimental data, but I knew no more about the structure
of ferrichrome than did the previous student. Neilands had just left for
a year's sabbatical leave in Sweden and England, and I was very discouraged. Ferrichrome is a relatively small molecule, and it is noted
for holding onto the iron extremely tightly. My chemical analyses had
shown that, in addition to one iron atom, ferrichrome contained three
molecules of acetic acid, three molecules of the amino acid, glycine, and
some ornithine, an amino acid which is rather rare in biological molecules. The amount of ornithine plagued me. Some days my analysis
would yield 1.5 molecules of ornithine, some days almost none at all.
At that time, one of the world's few functional amino acid analysis
machines was located in the laboratory of Dr. Heinz Fraenkel-Conrat
up in the virus area on the fifth floor, an area forbidden to graduate
students. The machine was being used to decipher the structure of the
coat protein of tobacco mosaic virus, work which would later bring fame
to Dr. Fraenkel-Conrat. The machine was operated by a postdoctoral
assistant to Dr. Fraenkel-Conrat, a gentle Japanese fellow named Dr.
Tsugita. One day at 2 o'clock in the morning I sneaked up on the fifth
floor and handed Dr. Tsugita a hydrolysate of ferrichrome, explaining
to him that I would be forever indebted if he would be willing to run my
sample through the amino acid analyzer. After making me promise that
Professor Fraenkel-Conrat would never know, he agreed to do it for me.
( Fraenkel-Conrat still does not know. I assume that he will not read this
essay.) I shall never forget my excitement the next day when Dr. Tsugita
came running up to me with his yards of paper recordings taken from
the machine. Of course, the three molecules of glycine clearly showed up,
but how much ornithine, I asked. None at all was the answer, but
instead Dr. Tsugita showed me a peak which agreed with no known
amino acid. Off to Val's Pizza Parlor to celebrate our discovery of a
new amino acid! Dr. Tsugita made me swear that I would not mention
'his name in my thesis for fear that Professor Fraenkel-Conrat would
throw him out of the lab for using the analyzer for something other than
tobacco mosaic virus.
One month later, after many long hours of experimentation and
much sweat, I was able to firmly establish the structure of the new
amino acid as a derivative of ornithine, 8-N-hydroxyornithine. It is the
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ammo acid ornithine in which one of the nitrogen atoms has been
substituted with an - OH group :
~H z

HzN - (CH Z)3- CH - COOH
ornithine

NH"
I
HO -NH -( CH z)3- CH - COOH
8-N -hydroxyornithine

This compound had never before been reported in the literature, and
only a few other examples of hydroxylamino acids were known. I realized that the reason for the previous ambiguous analyses was that traces
of iron would cause variable amounts of N-hydroxyornithine to be converted to ornithine during acid hydrolysis of ferrichrome. I was able to
put this fact to use in order to determine how much N-hydroxyornithine
was actually present in the ferrichrome molecule. By carrying out the
hydrolysis with hydriodic acid instead of hydrochloric acid, the - NOH
group was quantitatively reduced to an - NH2 group, yielding ornithine
cleanly. Exactly three molecules were found , proving that ferrichrome
itself contained three molecules of N-hydroxyornithine. Armed with
this information, I could account for all of the parts of the ferrichrome
molecule and correctly draw its complete structure :

FIGU RE

I. Th e stru cture of ferrichrome.

Consequently, instead of writing a monstrous thesis describing unsuccessful experiments on the ferrichrome molecule, I was able to write the
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shortest Ph.D. thesis in the department, entitled simply "The Structure
of Ferrichrome." One picture is worth 10,000 words to an organic
chemist!
Our first publication on the structure of ferrichrome appeared in
the Journal of the American Chemical Society in 1961 ( Emery and
Neilands, 1961). As so often occurs in science, within a few months
the structure of another siderochrome was published. A group in
Switzerland, unknown to our laboratory at that time, had independently
isolated an iron-chelating agent, which they called deferrioxamine, and
they had determined its chemical structure (Keller-Schierlein and Prelog,
1961 ) . Since that time, several dozen similar compounds have been
discovered. In fact, it appears to be a general rule that if a microorganism is starved for iron, it will excrete a siderochrome into the environment
to sequester that metal (Emery, 1978). It is interesting that microbiologists had previously overlooked this almost universal phenomenon
despite the fact that several grams df siderochrome are frequently produced in each liter of culture medium.
Examining the structure of ferrichrome or similar siderochrome
indicates that the Fe+++ is surrounded by six oxygen atoms located at the
six corners of a regular octahedron. This is the type of chelation chemistry that Fe+++ prefers. The groups which supply these oxygens are called
hydroxamic acids, - CO- NHOH. There are three of these in the ferrichrome molecule, each supplying two of the six oxygens that surround
the metal. When several chelating groups are found on the same molecule, a phenomenon called the "chelate effect" is produced, making the
affinity for the metal much greater than if the groups were on individual
molecules. Thus, ferrichrome binds Fe+++ approximately a million times
more strongly than simple hydroxamic acids. Although organic chemists
have known for almost three quarters of a century that hydroxamic acids
form strong complexes with iron, no one had ever thought of putting
three such groups on the same molecule to give a super iron-binding
substance. It is testimony to the power of evolutionary forces that this
mechanism was initially utilized by simple microorganisms over a billion
years ago. It also provides me with an excuse as to why I did not
discover the structure of ferrichrome sooner. No compound, either naturally occurring or synthetic, containing three hydroxamic acid groups was
known prior to the discovery of ferrichrome.
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Th e Role of Ferrichrome as Nature's G critol
How does ferrichrom e work to solve the cell's problem of iron
assimilation ? When faced with iron starvation , a complex control system
alerts the cell to impending disaster. Although we still do not understand
the molecular details, we do know that cellular protein synthesis is
diminished and cellular pools of amino acids are instead diverted to the
synthesis of deferriferrichrome, i.e., the organic part of the ferri chrom e
molecule lacking the iron. It is as if the cells realize that further synthesis
of proteins will be useless without iron. The deferrifcrrichrom e is
excreted from the cell where it solubilizes iron in the environment.
The iron-binding properties of this substance are so great that in the
laboratory iron is actually pulled out of Pyrex glassware or stainless steel !
In nature, oxides of iron are readily solubilized . When the Fe + is
chelated, each of the three hydroxamic acid groups loses a proton, 1P,
to leave three negative charges on the molecule. These three negative
charges balance the three positive charges of the Fe+++ to give an electrically neutral molecule. This is important because charged molecules
have a difficult time traversing cellular membranes. In addition, as the
ferrichrome wraps itself about the iron a dramatic change in shape,
called a conformational change, occurs. The cell can therefore readily
distinguish between the iron-free molecule, which is excreted, and the
iron chelate, which is taken up by the cells.
In 1957, my professor, J. B. N eilands, suggested that ferrichrome
acts as a transport agent to get iron into the cells (Neilands, 195 7) .
It was not until 1971 that work in my laboratory provided definit e
evidence that his suggestion was correct. The organism that produces
ferrichrome, Ustilago sphaerogena, possesses a specific transport system
which virtually sucks ferrichrome up from the surroundings, thus concentrating iron within the cells ( Emery, 1971 ) . It is generally believed
now that no metal ion can freely enter the cell. Specific chelating agents
are probably produced and act in a manner similar to ferrichrome to
sequester other essential metals, such as magnesium and zin c. Chelates
that carry metal ions into the cells are called ionophores, literally meaning " to carry ions." Ferrichrome can be considered to be a ferric
ionophore. The general term for an iron transport substance is siderophore, " to carry iron. " Ferrichrome was the first metal transport
H
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system to be examined, and it has been intensively studied during the
past decade.
Before leaving this discussion of iron transport, one final point
must be clarified. Cells utilizing a siderophore transport system have
seemingly painted themselves into a corner. They have succeeded in
accumulating iron, but it is in an unavailable form . Siderophores bind
iron so tenaciously that no other cellular substance is capable of removing it. The solution to this problem is simple and is based on the
principle that hydroxamic acids bind ferric, Fe+++, very strongly but they
have virtually no affinity for ferrous ion, Fe++. Thus, the cell merely has
to reduce the metal and it will be released from the chelate. Numerous
workers have shown that cells contain specific enzymes, called siderophore
reductases, which catalyze this reaction. Siderophores bind Fe+++ billions
of times more strongly than Fe+, and no other known substance shows
this extreme preference for the oxidized form of iron. Once the iron
has been removed, the organic portion of the molecule can be excreted
again to pick up some more iron. Ferrichrome thus acts as a "bucket
brigade," shuttling in and out of the cell carrying iron rather than water.

Who Cares?
Each month Senator William Proxmire awards to some scientist
what he calls the "golden fleece award." The award is made to the scientist who, in Senator Proxmire's opinion, has been given federal funds to
carry out a stupid research project. Over the past fifteen years, millions
of dollars of federal funds have been awarded to scientists around the
world in order to carry out basic research on iron metabolism in some
of the weirdest microorganisms imaginable. How can this be justified?
Out of fear that I may be the next recipient of the golden fleece award,
I would like to devote the remainder of this essay to discuss some of the
ways this research has led to practical benefits in terms of human health.

Iron Overload-Too Much of a Good Thing
Everyone is familiar with the problem of iron-deficiency anemia,
a problem in which too little iron is absorbed from the intestines into the
blood stream. The opposite problem, iron overload, is less well known
because it is much rarer. On the other hand, it is usually much more
senous. Unlike iron-deficiency anemia, iron overload is often fatal.
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There are basically two reasons why iron overload may occur. The first
is due to a rare disease, called haemochromatosis (Dreyfus and Schapira,
1960). For unknown reasons, people with this affliction absorb too
much iron. Most normal adults absorb about one milligram of iron per
day from the diet (menstruating women need about twice this amount
because of monthly blood losses ). In order to maintain iron balance,
we must also excrete one milligram of iron per day. Amazingly, humans
do not possess a metabolic mechanism to handle iron excretion. Iron is
apparently the only dietary element for which this is true. It is as if
Nature has had such a difficult time assuring the adequate assimilation
of iron that she decided that adequate iron excretion would never be
a problem. Fortunately for most of us, the average amount of iron lost
haphazardly each day almost exactly balances the amount we absorb.
Individuals suffering from haemochromatosis absorb about two
milligrams of iron per day, instead of one. Although this tiny amount of
iron does not even cover the head of a pin, it amounts to prodigious
quantities over the years. A normal individual contains three to four
grams total body iron. By the age of forty, an individual with haemochromatosis may have accumulated twenty or thirty grams of excess iron.
The excess iron is found in many tissues, such as the liver. Since the
tissue cannot hold such large amounts of iron, the metal actually deposits
and death often ensues. The abnormal iron deposits are actually visible
in the liver, and the disease is sometimes referred to as the "rusty
liver disease."
Haemochromatosis is a rare genetic disease, and most physicians
probably never encounter a case. However, there is another form of the
affliction which is far more common. It is called secondary haemochromatosis. In this case, diet plays an important role. Certain diets
greatly increase the amount of iron absorption. Excessive alcohol is an
example ( Geritol is 12 % alcohol). Cirrhosis of the liver is common in
alcoholics. Although alcohol is almost certainly the primary factor,
some investigators believe that the problem is exacerbated by increased
iron absorption. Secondary haemochromatosis is common in VA hospitals, where alcoholism is often encountered. Some people believe that
the ruddy complexion (and high incidence of liver problems) of people
living in southern France is not so much due to the sunny climate as it is
to the high iron content of southern French wines - as much as sixteen
milligrams per liter as compared to less than three milligrams per liter

9

for American wines. The most extreme example of secondary haemochromatosis occurs in the Bantus of South Africa, who brew a beer in
iron kettles. This beer, called kafir, contains over forty milligrams
per liter, and it is not uncommon for an average Bantu male to consume
over 100 milligrams of iron each day in the form of beer alone. Secondary haemochromatosis is a common form of death for Bantu males
(Bothwell, 1960).
Although primary haemochromatosis cannot be cured, it is obvious
that the problem might be alleviated if the body could maintain an
appropriate iron level. One way of doing this, still commonly practiced,
is bloodletting. Another possibility is to administer a chelating agent,
which would grab onto the metal and remove it from the tissues so that
it might be excreted in a harmless form in the urine. Unfortunately,
most chelating agents are not specific for one particular metal. A chelating agent such as ethylenediaminetetraacetate would not only effectively
remove iron, but also other essential metals, such as calcium and zinc.
As discussed above, however, siderophores produced by microorganisms
are highly specific for Fe+++, which is the form of the iron deposited in
the body. Vladimir Prelog, who was the leader of the Swiss group which
isolated deferrioxamine in 1961 and is a recent winner of the Nobel Prize
in chemistry, was the first individual to realize that this property of
deferrioxamine might be useful in treating haemochromatosis. In collaboration with a haematologist, he initiated treatment on a seventeen-yearold girl dying of primary haemochromatosis. The treatment consisted of
infusing over one gram per day of deferrioxamine into the patient.
The results were dramatic (see Figure 2). Although the normal excretion of iron in the urine is less than one milligram per day, immediately
after starting the treatment over fifteen milligrams of iron appeared in
the urine and reached a maximum of almost forty milligrams on the
tenth day. Similar results were obtained with other patients. Because of
the red color of the ferrioxamine chelate, the urine of patients during
treatment resembled port wine, which was very alarming to nurses not
alerted to the situtation !
Soon after the discovery of this medical use of siderophores, the
Ciba-Geigy pharmaceutical company started growing large quantities of
the microorganism and sending deferrioxamine to hospitals around the
world in fifty-pound sacks. This was most impressive to me, having
accomplished my thesis research on just a few hundred milligrams of
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2. Urinary excretion of iron in a patient suffering from
haemoc hromatosis after administration of deferrioxamine. Taken from Wohler ( 1960) .

ferrichrome. Deferrioxamine is now packaged under the trade name of
Desferal. Unfortunately, however, continued infusions of large amounts
of Desferal over long periods of time lead to undesirable side effects,
which is why bloodletting is still performed on haemochromatosis
patients. In the United States, the National Institutes of H ealth is
sponsoring ongoing research for the discovery or synthesis of new
siderophores which will not exhibit deleterious side effects. Why not
synthesize siderophores in the laboratory instead of being dependent upon
those supplied by microorganisms? In fact, both the Swiss and the
Japanese have reported the chemical synthesis of ferrichrome. However,
the synthesis is tedious and the yields are very poor. The problem lies
with the instability of one of the constituents of ferrichrome, namely,
N -hydroxyornithine.
A colleague, Dr. Richard Olsen, and I have recently been awarded
a National Institutes of H ealth grant to attempt a novel chemical synthesis of siderophores. You will recall that the iron is held in ferrichrome
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by three hydroxamic acid groups, - CO-NOH. If one imagines the
hydroxamic acid groups to be excised from the molecule and turned
around, the following structural change would occur:

~H3

c=o
I

<;:H3

c=o
I

<;:H3 ~H3
N-OH N-OH

/(H3

c=o
I

I

c=o

N-OH N-OH N-OH

~~~
(
~(
(GIY)3
ferrichrome
FIGURE

I

c=o

(GIY)3
side-chain retroferrichrome

3. Chemical comparison of ferrichrome and side-chain retroferrichrome.

We call this new compound side-chain retroferrichrome. Inspection of
molecular models indicates that this change would have little or no effect
on the iron-binding center. Side-chain retroferrichrome should bind
iron as well as ferrichromc itself. Although the two structures may
appear similar, they are dramatically different to the synthetic organic
chemist. Whereas in ferrichrome the - N- OH group is supplied by
N-hydroxyornithine, in the new compound it is supplied by methylhydroxylamine, CHaNHOH, a substance that can be bought in pound
quantities. The amino acid attached to the ring system is no longer
the rare, unstable, N-hydroxyornithine, but rather a substance called
a-aminoadipic acid, which is also readily available commercially. Thus,
side-chain retroferrichrome should be relatively easy to synthesize in the
l.aboratory. We should also be able to make alterations in the molecule
during chemical synthesis, and thus build into the molecule chemical and
physical properties, such as greater or lesser water solubility, that might
be medically advantageous. Availability of a series of synthetic derivatives
could lead to the discovery of a substance that would not only be more
effective in removing iron from the body, but could also be administered
orally. In a recent symposium on iron metabolism, several participants
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agreed, "There is consequently a serious need to develop iron chelating
agents which can be used to combat iron overload. Unfortunately, those
in common use today are not very satisfactory; they are by no means
as effective as could be hoped and oral administration is not currently
possible due to poor absorption" (May et at., 1978). We hope that our
research may alter this situation, and at the same time avoid our becoming recipients of Senator Proxmire's golden fleece award.

I ron Poisoning
Every year many small children around the world die of iron
poisoning. It has been estimated that 10% of all childhood deaths from
poisoning may be attributed to iron. We may ask two questions. First,
why is a substance so essential to good health also poisonous? Second,
why is iron poisoning so common? We do not know the answer to the
first question. For unknown reasons, large amounts of iron cause massive
tissue destruction in the gastrointestinal tract. Ingestion of large amounts
of iron salts causes vomiting, collapse of the vascular system, and often
death. The answer to the second question is simple - ignorance on the
part of the parents. It is common medical practice for physicians to
prescribe iron supplements for women during the third trimester of
pregnancy. This is necessary to insure that the newborn will be supplied
with an adequate amount of iron during the first few months of life.
Consequently, bottles containing several grams of iron are often found
within easy reach on the kitchen or bathroom shelf. It has always seemed
incredible to me that aspirin is packaged in bottles requiring the intelligence of Einstein and the strength of a gorilla to open, while bottles
containing iron supplements can be opened easily with one hand. I also
consider it an obscenity that the manufacturers of these supplements
place the iron in candy-coated tablets, which closely resemble M & M
candy. Thus, the small child supposedly sneaking a handful of candy
actually may swallow several grams of iron. It is indeed tragic that by
attempting to guarantee the health of her unborn child, a woman may
carelessly cause the death of another child in the house.
Several cases of childhood iron poisoning, and at least one case of
adult iron poisoning, have occurred in the Cache Valley area within the
past few years. Much to my dismay, one example is the child of a friend
of mine in Smithfield. Fortunately, to the best of my knowledge, the
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individuals are still alive-thanks to microbial iron metabolism. Desferal
has found clinical use not only in cases of chronic iron overload, but
also in cases of acute iron poisoning. Toxicology centers and hospital
pharmacies now usually have Desferal on hand. Large quantities of
this natural iron-chelating agent are quickly administered to the patient.
The Desferal travels throughout the body and rapidly binds the unwanted
metal. The harmless Desferal-iron chelate, ferrioxamine, is excreted in
the urine.

Iron and Infectious Disease
I would now like to turn to an area of human iron metabolism that
has only recently received attention and is still somewhat controversial.
This aspect of iron metabolism is not discussed in medical school curricula and is not generally appreciated by most practicing physicians.
As previously mentioned, virtually all living cells require iron for
growth and survival. One way to prevent bacteria from growing, and
thus to prevent an infection, is to deprive them of iron. Nature apparently discovered this obvious fact a long time ago. Egg whites contain
an interesting protein called conalbumin. Conalbumin, sometimes called
ovotransferrin, is very interesting in that it tightly forms a chelate with
Fe+++. In fact, it is one of the few natural products which has an
affinity for Fe+++ comparable to microbial siderophores. Unlike siderophores, the iron is not held by hydroxamic acid groups, but rather by
specific amino acid residues that surround the metal. Is this property
of conalbumin merely fortuitous, or is there a reason? Most researchers
in iron metabolism believe the latter. Eggs are an excellent incubation
medium for bacterial growth. And eggs crack. Eggs are not usually
located in the most sterile of environments, and a cracked egg is vulnerable to bacterial infection. If this happened frequently, the species
could not survive. We believe that nature supplied the egg with
conalbumin to protect it from infection. All the available iron is chelated
by the protein, and it is thus unavailable for bacterial growth. This is
readily observed in the laboratory. A small amount of conalbumin added
to a bacterial culture prevents growth. We can only speculate as to how
important this phenomenon is in nature. However, a former student of
Professor Neilands, John Garibaldi, made an interesting observation
several years ago (Garibaldi, 1962). At that time there was a severe
problem with egg spoilage in certain regions of central California.
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Dr. Garibaldi reasoned that if the well water used by ranchers to wash
eggs contained a high concentration of iron, the conalbumin might
become saturated with the metal. Once the capacity of conalbumin was
exceeded, the excess iron would be available for bacterial growth, leading
to spoilage. Dr. Garibaldi tested this hypothesis by analyzing the well
water of different chicken ranches for iron content. He found a direct
correlation between iron content and the amount of egg spoilage.
Might such a mechanism operate in animals, including humans?
The answer is probably yes. Certain parts of the body are especially
vulnerable to infection. The eyes are an example. The mucous membranes of the eye are constantly exposed to airborne bacterial infection.
Dr. Alexander Fleming, the discoverer of penicillin, observed long ago
that tears contained an enzyme, lysozyme, which catalyzes the destruction of bacteria by breaking apart their cell walls. The reader may be
interested to know that the commercial source of lysozyme today is not
tears, but egg white. If eggs contain both lysozyme and conalbumin for
protection, might not the eyes also? While I was still a student in
Neilands's lab, I considered this possibility and carried out some preliminary experiments. Unfortunately, I could reach no conclusion. More
recently, however, other scientists have indeed found that tears contain a
protein that is extremely similar to conalbumin. It is called lactoferrin,
and it binds iron almost exactly as strongly as conalbumin (Hoffer et al.,
1977). Because lactoferrin is not known to play any other biological role
than binding iron, it seems logical to conclude that its role in the eye is to
inhibit bacterial infection in the same manner that conalbumin protects eggs.

Too il1uch of a Good Thing
If a scarcity of available iron prevents bacterial growth, might not
an individual's susceptibility to infectious diseases be closely related to
his or her iron nutrition? Although there is no evidence at present that
eye infections are related to iron abundance, there is an increasing body
of medical literature that such a relationship does exist in blood.
When most of us think about iron in humans, we rightly think of
blood. About 75 % of all of our iron occurs in the blood, and most
people know that the red color of blood is due to the iron-containing
protein, hemoglobin. You would hardly think that a bacterium entering
the blood through a cut or a scratch would have to worry about a
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scarcity of iron. But this is exactly what occurs. The iron is packaged
inside of the red blood cell and is not accessible to the bacterium.
In fact, it is not even accessible to the other cells of the body. Nevertheless, our blood is responsible for transporting iron from the intestinal
tract, where it is absorbed, to all other tissues. This is not the role
of hemoglobin, however, but rather this job is delegated to a protein
called transferrin, occurring in the plasma rather than in the red blood
cell. Transferrin is a protein perfectly designed to bind Fe+++ strongly,
and it may come as no surprise at this time to learn that transferrin
bears an amazing resemblance to lactoferrin and conalbumin.
For all practical purposes, the only available source of iron for a
microorganism finding itself in the bloodstream is the iron bound by
transferrin. But transferrin binds iron with an extraordinary tenacity.
How can the microorganism remove it? Simply by doing what it does
under our laboratory conditions of iron deprivation, that is, by excreting
a siderophore into the blood plasma. The binding strength of siderophores and transferrin for Fe+++ is almost identical, so a competition
begins between your own transferrin and the microbial siderophore.
If the siderophore wins, you are faced with an infection. This relationship between the iron nutritional status of an individual and the susceptibility to infectious disease has been discussed in detail by E. D. Weinberg
( 1978). I would like to cite a specific example.
About ten years ago it was common practice in certain New Zealand
hospitals to give iron supplements to infants soon after birth (Barry and
Reeve, 1973). This practice was stopped when it was found that the
incidence of certain bacterial infections was eight times higher in the
treated infants than in infants who were left alone. Thus, in a wellintentioned effort to make children "stronger" by increasing their iron
levels, the doctors were actually increasing the chances that children
would be exposed to potentially fatal infections. According to Sussman,
"Iron plays an important part in determining virulence and possibly even
pathogenicity in experimental infection" (Sussman, 1974 ) . Weinberg
. has called this phenomenon "nutritional immunity. "
According to the concept of nutritional immunity, an animal may
protect itself against certain infections by maintaining its iron nutritional
status at a lower level than is commonly thought to be ideal for good
health. A rosy complexion has always been regarded as a sign of health.
Within the past few years, however, a large body of medical research
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is beginning to suggest that borderline iron-deficiency anemia may not
always be as bad as it appears at face value. It has been known for a
long time that at the onset of some infections, iron absorption from the
intestines rapidly decreases. This observation is easy to interpret if one
accepts the concept of nutritional immunity, i.e., the body is making
every effort to deprive invading microorganisms of iron to delay their
growth so that our immune system can destroy them. A human will not
die if deprived of iron for days, or even weeks. Rapidly growing bacteria
cannot fare so well without iron. As previously mentioned, because of
menstrual iron losses women have greater demands for dietary iron than
men. Women tend to suffer from iron-deficiency anemia much more
than men. Is it not possible that women's greater resistance to infection is
related to their lower levels of body iron?

Babies and I ron Nutrition
Except for the immediate threat of starvation, infection poses the
greatest hazard for the survival of the newborn child. Like eggs, the
infant is constantly exposed to bacteria. It is not surprising that nature
has evolved numerous devices to protect the infant; without such protection, it is likely that none of us would be here. In this section I would
like to briefly discuss infant survival with respect to iron nutritional status.
It is generally agreed that human milk is the ideal food for the
newborn. Beverly Winikoff has written a fascinating article relating
breast feeding to nutrition, population, and health ( Winikoff, 1978).
Breast milk not only contains a near ideal combination of easily digestible
foods, but also an array of substances designed to immunize the child
against infection. Surely iron, the indispensable element for life, has not
been overlooked? An article clipped from the Logan Herald Journal of
October 15, 1978, describes the concern of doctors about iron malnutrition in infants. The article states that "iron must be replaced through
iron from breast milk ... ." This is nonsense! Cow's milk contains less
than one milligram of iron per quart, and human milk contains even less.
To make matters even worse, milk contains the iron-binding protein
lactoferrin. When lactoferrin binds iron, it changes its structure and
becomes extremely difficult to be digested by intestinal enzymes. Nature
has seemingly made every effort to make iron unavailable to the newborn
child. How could she have erred so badly?
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Iron experts believe that Nature has not erred at all, but rather that
iron is purposely kept from the diet in order to protect the child from
infection. Unlike the well-intentioned New Zealand doctors mentioned
above, supplemental iron is actually kept away from the infant. Babies
are born with more than enough iron to take care of their needs for
months-just how many months is a matter of controversy. A great deal
more research is needed to decide when, or if, supplemental iron should
be added to the diet.
There is an interesting sidelight to the low levels of iron in the diet
of breast-fed infants and the development of the child's digestive system.
As far as we know, iron is required by all forms of life with one excep. tion. The exception is the lactic acid bacteria. No one has yet been able
to demonstrate an iron requirement for these organisms. These bacteria
are found in the digestive tract of young animals, and they digest lactose,
or milk sugar, so that the digestion products are absorbable by the
intestine. Because of the virtual absence of iron in milk and the strong
binding of what little iron there is by the lactoferrin protein, it is obvious
that a microorganism could thrive in an infant's intestinal tract only if
it had a negligible requirement for iron.

I ron and Fever
Warm-blooded animals have an elaborate physiological control
system to maintain a constant body temperature. In man, this temperature is about 37°C. Any significant deviation from this temperature puts
stress on the body and makes it difficult to maintain metabolic processes
at their normal rates. Why then, during sickness, should the temperature
rise? It would seem that development of fever would cause things to go
from bad to worse, and make it more difficult for the body to recuperate.
Fever is a complex and little understood phenomenon. Nevertheless, it is
becoming more and more evident that fever can, in fact, be very beneficial to an organism. It is common practice today to make every effort to
reduce fever during illness. It would not surprise me at all if in the
future we are told to let a fever run its course because of its benefit to
the recuperative processes. I would like to discuss one aspect of fever as it
relates to iron metabolism and infectious disease.
Professor Matthew Kluger has recently written an article on the
evolution and adaptive value of fever (Kluger, 1978). He cites an
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interesting study by Vaughn, who investigated the survival of desert
lizards, iguanas, after infection with a pathogenic bacterium. Reptiles
cannot regulate their body temperature. When placed in a chamber that
is held at SO°C at one end and 30°C at the other end, they will move
back and forth to try to adjust their bodies to a preferred temperature
of 38 ° C. However, after infection, they spent more time at the hot end
of the chamber, purposely raising their body temperature. If they were
not allowed to do this, their survival rate decreased. Below is a graph
of a similar study by Kluger and collaborators who infected iguanas
with bacteria and then kept groups of the infected lizards at different
temperatures.
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A. hydrophila, and then maintained at various temperatures. Numbers
in parentheses are total number of animals in test group. From Kluger
(1978 ).

19

7

The graph clearly shows that lizards held at "fever" temperature of
42 °C survived quite well - much better than the animals held at their
good health-preferred temperature of 38 ° C. The article goes on to cite
similar studies with warm-blooded animals.
Although the protective value of fever during infection must certainly be very complicated, I would like to point out one aspect which is
related to iron. In the course of his studies on microbial siderophore
biosynthesis, Garibaldi made an interesting observation (Garibaldi,
1972). If the temperature of cultures was raised a few degrees above
the normal growth temperature of 37 ° C, the organisms would survive
quite well, but they ceased to produce siderophores. Garibaldi was the
first to point out the possible medical significance of . this observation.
Without iron, the bacteria cannot grow within the body. We have seen
that during infection the body restricts the levels of blood plasma iron
in order to make it more difficult for the microbes to grow. It may be
possible that one of the reasons that fever is produced is to inhibit the
ability of the microorganism to produce siderophores, which might otherwise effectively compete for the last traces of iron in the blood plasma.
Thus, normal body temperature and adequate iron nutrition may be
just fine for people in good health, but may actually be detrimental at
the onset of infection.
Over 300 years ago, Sydenham said that "fever is a mighty engine
which Nature brings into the world for the conquest of her enemies."
Perhaps loss of appetite to restrict iron intake is one of the pistons of
that engine. A popular old wives' tale is to "feed a cold but starve a
fever." Fevers may be caused by bacterial infection, the infection being
slowed by lack of iron. Colds are caused by viruses. Viruses do not
contain iron!

I ron and Plants
It would be amiss for a professor at a land grant university, whose
students are called Aggies, to conclude a discussion of iron without a
word about the role of this element in agriculture. Just as in animals,
many of the enzymes essential for plant life require iron. Perhaps most
important, the biosynthesis of the green pigment, chlorophyll, also
requires iron. Lack of iron leads to diminished chlorophyll synthesis and
a yellowing of the plant. Such a condition is called chlorosis. Chlorosis is
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common in alkaline soils, such as are often found in Utah, because of
the extreme insolubility of oxides of iron in alkaline solution. Without
sufficient chlorophyll, plants cannot carry out photosynthesis, and greatly
diminished crop productivity results. Farmers and horticulturists have
long recognized this problem and have made strenuous efforts to solve it.
Many years ago children in Hawaii earned pocket money by taking iron
turnings from foundry lathes and placing one turning on the top of each
pineapple plant in the plantations. The acidity of these plants is apparently sufficient to solubilize metallic iron. Today, synthetic iron chelates
are used. The spraying of many tons of commercial iron chelates on
agricultural crops, as well as on residential lawns, is a multimillion
dollar industry.
Most commercial iron chelates used for agricultural purposes are
derivatives of a substance called ethylenediaminetetraacetate, or EDTA.
EDTA forms a very stable chelate with Fe++..., and it is surprising that
plants are able to remove the metal from this foreign compound.
In order to do this, they must completely degrade the EDTA itself by
metabolic processes. The final products of EDT A degradation are not
known, but it is interesting that EDT A contains organic amines, which
in some cases are known to be metabolically converted to cancerproducing compounds. When one considers the many tons of EDTA
sprayed on crops each year, it would appear that this is one area thus far
overlooked for criticism by environmentalists.
Quite obviously, plants were around long before EDTA was
invented. How do plants cope with iron deficiency in nature? There is
no evidence that higher plants mimic microorganisms and excrete siderophores. However, they often excrete from the root system a complex
mixture of organic acids. This mixture is generally called "humic acid."
These acids apparently play the same role in plant iron metabolism that
siderophores do in microorganisms. The soil becomes more acidic, thus
increasing the solubility of iron. Furthermore, many of the acids, such as
citric acid, are respectable chelators of iron, although not in the siderophore class. Thus, plants make use of the same two principles for
obtaining iron-acidity and chelation. Sometimes, this may actually
work to the disadvantage of the plant. If the soil under the plant is
porous, the solubilized iron may actually drain away from the root
system. Epstein gives a dramatic example of this in the Kauri pine,
Agathis australis, in New Zealand (Epstein, 1972). The tree is growing
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on soil rich in oxides of iron, but the humic acids excreted by the tree
have leached the iron away from under the tree, leaving a base of pure
white silica behind.
Although higher plants do not synthesize siderophores, I believe that
siderophores may play an important role in plant iron nutrition. Species
of the fungus fusaria are commonly found growing on plant roots.
About fifteen years ago we found that this fungus excretes a powerful
iron-binding siderophore, fusarinine C, when grown under iron deprivation. In laboratory experiments, we subsequently found that fusarinine C
could .be taken up by the root system of soybeans and tomatoes, and the
iron was distributed to the leaves. Although growth of this fungus on
plant roots is considered to be a pathological condition for the plant,
it may be that under certain conditions a symbiotic relationship occurs
wherein the soil microorganisms provide siderophores which serve to
supply iron to the plants. This possibility has never been seriously
investigated, although we have shown that siderophores are always found
in randomly collected soil samples. If it were not for economic considerations, the use of siderophores rather than EDTA in agricultural
applications would be far more ecologically sound.
Another observation that suggests that microbial siderophores may
play an important role in iron nutrition in plants was reported by
Neilands in an article entitled, "Ferrichrome Mimics the Green Island
Effect" (Atkin and Neilands, 1972). It is sometimes observed that leaves
yellow with chlorosis have small patches of green, which are called
"green islands." They sometimes occur at the site of virus infection.
Neilands made the interesting observation that green islands could be
produced on leaves by the application of trace amounts of ferrichrome.
The effect is specific for ferrichrome and can be produced by amounts
as small as ten nanograms! These results strongly imply that ferrichrome
is specifically supplying catalytic amounts of iron to allow chlorophyll
synthesis to proceed in an otherwise defective leaf.
Another line of evidence implicating siderophores in plant iron
metabolism relates to copper. Plant scientists have long known that the
presence of high concentrations of copper in the soil antagonizes the
assimilation of iron, which leads to chlorosis. Copper is chemically very
different from iron, and there is no obvious biochemical relationship
between these two metals to suggest an explanation for the copper
effect. However, it is known to chemists that hydroxamic acids - the
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fundamental chelating groups of many siderophores-chelate with copper
to form an insoluble blue precipitate. I observed many years ago that if
the iron is removed from ferrichrome and copper is added to the colorless
solution, a blue precipitate quickly forms. I would suggest, therefore,
that when soil microorganisms excrete iron-free siderophores in their
attempt to sequester iron from the soil, the copper-siderophore complexes
precipitate and become unavailable for iron metabolism for both the
microorganism and the plant. Although iron is bound to siderophore
ligands much more strongly than copper, the latter metal is much more
soluble, and the precipitation occurs before the iron has a chance to bc
solubilized. Once the copper precipitate forms, it would be very difficult
for iron to displace copper from the insoluble copper chelate. No one has
ever examined soils in copper-rich regions to sec if copper-siderophore
chelates are present.

Conclusion
In spite of many years of intensive research, some of the most fundamental problems of human iron metabolism remain unsolved, for
example, the mechanisms by which iron is absorbed from the intestine
and later released to the tissues according to need. Because of the relative
simplicity of microbial systems, advances have come more quickly in this
area. The detailed mechanism of iron transport in microbes is now quite
well understood, and hopefully this understanding will be of value to
future researchers in the medical sciences.
I have described in this essay some of the ways in which research
in microbial iron metabolism have already found applicability in medicine. Microbial iron transport agents-the siderophores-are routinely
used to remove excess metal in iron-storage diseases. Siderophores are also
used as antidotes in cases of accidental iron poisoning in children. More
recent work suggests that some accepted ideas about iron nutrition might
have to be discarded. The prevalent attitude fostered by high-pressure
advertising that "the more iron the better" may have to be reevaluated
by a society that has become used to eating breakfast cereal with a
magnet rather than a spoon. The common practice of iron supplementation in infancy must certainly be questioned, and the relationship of
iron to fever and infectious disease should be a matter of intensive
future research. In 1956, when Professor Neilands suggested to me that
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working on microbial iron transport compounds might be an interesting
problem for a Ph.D. thesis, neither of us could have guessed that this area
of research might have so many future practical applications in the
medical sciences.
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